Entry Detail



General Information

Database ID:exR0092175
RNA Name:hsa-miR-4709-3p
RNA Type:miRNA
Chromosome:chr14
Starnd:-
Coordinate:
Start Site(bp):74480135End Site(bp):74480157
External Links:hsa-miR-4709-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
BCORL1
chrX
129981107
130058083
+
COQ8A
chr1
226897536
226987545
+
DNAJB6
chr7
157335381
157417439
+
LAMC1
chr1
183023420
183145592
+
PURA
chr5
140107777
140125619
+
TMEM167A
chr5
83052846
83077863
-
BIK
chr22
43110750
43129712
+
CLSTN3
chr12
7129698
7158945
+
DHX16
chr6
30653119
30673006
-
EMC4
chr15
34225013
34230156
+
ETV3
chr1
157121191
157138474
-
GATM
chr15
45361124
45402327
-
MED1
chr17
39404285
39451272
-
MED28
chr4
17614641
17634105
+
MSH3
chr5
80654652
80876815
+
MTRNR2L12
chr3
96617188
96618236
-
NDUFA4
chr7
10931943
10940153
-
NPC2
chr14
74476192
74494177
-
PLBD1
chr12
14503661
14567883
-
PLEKHA5
chr12
19129752
19376400
+
RACK1
chr5
181236897
181248096
-
RBM15B
chr3
51391285
51397908
+
SLC50A1
chr1
155135344
155138857
+
TPRG1L
chr1
3625015
3630127
+
WNK1
chr12
752579
911452
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:NA
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.